Loading Map....

Date/Time
Date(s) - 04/28/2015
12:00 pm - 1:15 pm

Location
Hanson Bridgett LLP


Claim Construction after Teva Pharmaceuticals

Click here to register.

With its decision on January 20, 2015 in Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.the Supreme Court changed the law of claim construction, holding that the Federal Circuit must apply a “clear error,” not a de novo, standard of review, when reviewing a district court’s resolution of subsidiary factual matters made in the course of its construction of a patent claim.

In this presentation, two experienced patent litigators, Michael Carlson and  Robert McFarlane will share their insights into how the Teva decision is changing patent litigation.

 Presenters:

Carlson2009_72ppi-bwMichael M. Carlson is a partner at Schnader Harrison experienced in many areas of commercial litigation, with particular expertise in intellectual property litigation. He has federal and state trial experience in both civil and criminal matters, has argued cases before the U.S. Court of Appeals for the Federal Circuit and several districts of the California Court of Appeal, and has been involved in appeals before the U.S. Court of Appeals for the Ninth Circuit and the California Supreme Court. Mr. Carlson is chair of Schnader’s Intellectual Property Litigation Practice Group, and is also the president of the San Francisco Intellectual Property Law Association (SFIPLA).



McFarlane_Rob-123r_113x167bw
Robert A. McFarlane chairs Hanson Bridgett’s Technology Practice and is a registered patent attorney. His litigation practice focuses on patent infringement matters, intellectual property disputes, and technology-related commercial disputes. He also provides his clients with counseling on a wide range of intellectual property matters relating to licensing negotiations, trademark and copyright, unfair competition, and trade secrets. He advocates on behalf of clients ranging from individuals to multi-national corporations, often in cases involving the threat of injunctive relief with potential damages of tens or hundreds of millions of dollars. He has argued cases before the Federal Circuit and the California Courts of Appeals, and represents his clients in courts throughout the United States, including such significant patent litigation jurisdictions as the Eastern District of Texas, the Eastern District of Virginia, the Northern District of Illinois, the District of Delaware, and the Northern and Central Districts of California. He is also experienced with matters filed in the International Trade Commission (ITC) and the Trademark Trial and Appeal Board (TTAB).

Location:

Hanson Bridgett LLP, 425 Market, 26th Floor, San Francisco, 94105

Price and Registration:

Ticket Type Price (Before Ticketing Fees)
In-Person In-House Counsel Free
In-Person SFIPLA Member (Law Firm) $35
In-Person Non-Member $40
Student $10

Click here to register and pay on-line, or mail your RSVP, desired ticket type, and check made payable to SFIPLA to us at the address on our contact page.

 

Categories

0